Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
90 participants
OBSERVATIONAL
2010-03-31
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Measures such as approximate entropy and sample entropy have shown great potential in the evaluation of the complexity of the respiratory system, providing information relevant to the understanding of physiological and pathophysiological processes. These measures are based on the concept of non-linearity in the presence of a high number of interconnections, resulting in the complex behavior exhibited by physiological systems.
The approximate entropy (ApEn) is related to the amount of clutter, complexity or unpredictability of a data series over time. In a complementary way, the sample entropy (SampEn), is a far more elaborate than the ApEn, to reduce possible biased estimates due to self-similarity.
A study conducted by our group in asthma patients with different levels of bronchial obstruction demonstrated a significant reduction in airflow approximate entropy (ApEnV´) in asthmatic subjects. Investigators believe that in COPD, similar to that which occurs in asthma disorders that are associated with complex changes in the pathophysiology triggering breath control, possibly resulting in changes in air flow (V´).
Considering the development "silent" changes of mechanical ventilation in COPD patients and its clinical relevance, as well as the difficulty of identifying such changes through conventional methods, we observed the need to obtain more detailed information, including the complexity of the system breathing for better understanding of factors that contribute to the illness.
In this context, the objectives of this study were: (1) analyze the influence of airway obstruction in the complexity of the patterns of airflow in patients with COPD, (2) evaluate the diagnostic power of the test in identifying the changes caused by COPD.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control group
Group of nonsmokers individuals without respiratory disease.
No interventions assigned to this group
NE
Smokers wiht normal spirometry.
No interventions assigned to this group
LV
Patients with COPD level I, mild.
No interventions assigned to this group
MOD
Patients with COPD level II, moderate.
No interventions assigned to this group
GV
Patients with COPD level III, severe.
No interventions assigned to this group
MGV
Patients with COPD level IV, very severe.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* volunteers without any respiratory disease for the control group.
Exclusion Criteria
* heart disease in general and
* disability in the exams.
40 Years
90 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Conselho Nacional de Desenvolvimento Científico e Tecnológico
OTHER_GOV
Rio de Janeiro State Research Supporting Foundation (FAPERJ)
OTHER_GOV
Rio de Janeiro State University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Karla Dames
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pedro L de Melo, DSc.
Role: STUDY_DIRECTOR
State University of Rio de Janeiro
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Laboratório de Instrumentação Biomédica
Rio de Janeiro, Rio de Janeiro, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Karla Dames, Principal Investigator
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Silva KK, Faria AC, Lopes AJ, Melo PL. Within-breath respiratory impedance and airway obstruction in patients with chronic obstructive pulmonary disease. Clinics (Sao Paulo). 2015 Jul;70(7):461-9. doi: 10.6061/clinics/2015(07)01. Epub 2015 Jul 1.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UERJ-DPOC-01
Identifier Type: -
Identifier Source: org_study_id